Peter Ruf
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 15
-
- Immunotherapy and Immune Responses 8
- Co-authors
- Horst Lindhofer (26 shared papers)Michael Jäger (5 shared papers)Juergen Heß (5 shared papers)Alexandra Schoberth (3 shared papers)Matthias Plöscher (2 shared papers)M. M. Heiss (2 shared papers)Marc C. Winslet (1 shared paper)Kevin M. Sales (1 shared paper)
- Journals
- Cancer Research (3 papers)British Journal of Cancer (2 papers)Annals of Oncology (2 papers)International Journal of Cancer (2 papers)Blood (1 paper)
- Partner nations
- GermanyIsraelUnited Kingdom
In The Last Decade
Peter Ruf
27 papers receiving 969 citations
Peers
Comparison fields: 5 of 46
- Radiology, Nuclear Medicine and Imaging 506
- Oncology 285
- Immunology 169
- Reproductive Medicine 54
- Pathology and Forensic Medicine 42
Countries citing papers authored by Peter Ruf
This map shows the geographic impact of Peter Ruf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ruf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ruf more than expected).
Fields of papers citing papers by Peter Ruf
This network shows the impact of papers produced by Peter Ruf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ruf. The network helps show where Peter Ruf may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ruf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 144 | |
| 2 | 2010 | 120 | |
| 3 | 2011 | 97 | |
| 4 | 2007 | 88 | |
| 5 | 2009 | 83 | |
| 6 | 2007 | 81 | |
| 7 | 2010 | 74 | |
| 8 | 2008 | 60 | |
| 9 | 2016 | 59 | |
| 10 | 2003 | 42 | |
| 11 | 2012 | 37 | |
| 12 | 2008 | 34 | |
| 13 | 2012 | 24 | |
| 14 | 2011 | 19 | |
| 15 | 2021 | 17 | |
| 16 | 2015 | 14 | |
| 17 | 2021 | 12 | |
| 18 | 2016 | 10 | |
| 19 | 2011 | 9 | |
| 20 | 2013 | 8 |
About Peter Ruf
Peter Ruf is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Neurology and Pathology and Forensic Medicine, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lymphoma Diagnosis and Treatment (2 papers), HER2/EGFR in Cancer Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Neuroblastoma Research and Treatments (2 papers) and Ocular Oncology and Treatments (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (506 citations), Oncology (285 citations), Immunology (169 citations), Reproductive Medicine (54 citations) and Pathology and Forensic Medicine (42 citations). Peter Ruf has collaborated with scholars based in Germany, Israel and United Kingdom. Frequent co-authors include Horst Lindhofer, Michael Jäger, Juergen Heß, Alexandra Schoberth, Matthias Plöscher, M. M. Heiss, Marc C. Winslet, Kevin M. Sales, Pauline Wimberger and Karin Fellinger. Their work appears in journals such as Cancer Research, British Journal of Cancer, Annals of Oncology, International Journal of Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.